Search

Search Results

• 

  Clarification to provide further understanding of the conduct and design of TROPIC: A Phase 3 trial of cabazitaxel versus mitoxantrone in patients with metastatic castration-resistant prostate cancer

  Johann de Bono, Liji Shen, Oliver Sartor

  72-73

  2016-03-31

  Published: March 31, 2016

  2407

  PDF: 1163
• 

  Reply to: Clarification to provide further understanding of the conduct and design of TROPIC: A Phase 3 trial of cabazitaxel versus mitoxantrone in patients with metastatic castration-resistant prostate cancer

  Gianpaolo Perletti

  74-75

  2016-03-31

  Published: March 31, 2016

  1600

  PDF: 1101
• 

  Efficacy and safety of second-line agents for treatment of metastatic castration-resistant prostate cancer progressing after docetaxel. A systematic review and meta-analysis

  Gianpaolo Perletti, Elena Monti, Emanuela Marras, Anne Cleves, Vittorio Magri, Alberto Trinchieri, Paul S. Rennie

  121-129

  2015-07-07

  Published: July 7, 2015

  10579

  PDF: 4489

  SUPPLEMENTARY MATERIAL: 1008